Repository logo
 

Cell-specific mechanisms drive connectivity across the time course of Huntington's disease.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Hyperconnectivity in functional brain networks occurs decades before disease onset in Huntington's disease. However, the biological mechanisms remain unknown. We investigate connectivity in Huntington's disease using Morphometric INverse Divergence (MIND) in three Huntington's disease cohorts (N = 512) spanning from two decades before the onset of symptoms through to functional decline. Here, we identify stage-specific profiles, with hyperconnectivity 22 years from predicted motor onset, progressing to hypoconnectivity through the late premanifest and manifest stages, showing that hypoconnectivity is correlated with neurofilament light concentrations. To understand the biological mechanisms, we investigate associations with cortical organization principles including disease epicentres and cell-autonomous systems, in particular neurotransmitter distribution. The contribution from disease epicentres is limited to late premanifest while cell-autonomous associations are demonstrated across the Huntington's disease lifespan. Specific relationships to cholinergic and serotoninergic systems localized to granular and infragranular cortical layers are identified, consistent with serotoninergic layer 5a neuronal vulnerability previously identified in post-mortem brains.

Description

Acknowledgements: To the patients and their families. We would like to express our gratitude to Dr Raymund AC Roos for his significant contributions to the Track-HD and TrackOn-HD cohorts as a principal investigator. S.J.T. is partly supported by the UK Dementia Research Institute that receives its funding from DRI Ltd., funded by the UK Medical Research Council award number (DRI-TAP24/28). C.E.-F., S.G., R.I.S., G.R., and S.J.T. received support from a Wellcome Collaborative Award (200181/Z/15/Z). E.J.W. was funded by Medical Research Council (MR/M008592/1), European Huntington’s Disease Network and CHDI Foundation. LMB was funded by a Medical Research Council Career Development Award (MR/W026686/1).


Funder: Dementia Research Institute DRI-TAP24/28

Journal Title

Nat Commun

Conference Name

Journal ISSN

2041-1723
2041-1723

Volume Title

16

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Wellcome Trust Ltd (200181/Z/15/Z)